Wednesday, November 12, 2014 9:35:59 PM
Can I ask a few questions if you have a minute?
Can you describe the differences between GALT's developments (and success so far) and the developments and advancement/stages/ etc of GALT's Competitors? and is there any reason to be concerned that other biotechs are winning the race versus GALT? and/or is this an irrelevant issue.
Can you see a fundamental time frame as to when GALT will make a big breakthrough in the next fundamental catalyst for price. Is it 5 or 6 months away or longer?
Can the fundamental analyst explain with good understanding Why the share price has collapsed 75 % from the 19 dollar top?
was 19 dollars an extreme overvalue? or is the 5 dollar zone an extreme oversold panic?
You mentioned GALT needs to attract Institutional investors.... does its competitor have Institutional investors, are they far ahead of GALT in that way?
and at what price would institutional investors decide to jump in,if not the 4.50 bottom zone? would they rather buy in at 7 dollars ? or.... does their decision to invest in GALT hinge upon the Cohort results, or some other development?
and what is the time frame of achievement that will make investors decide to pony up.
As far as the Technical picture....I never expected to see GALT fall much below 9.60....and below that the 7.50 area was an extreme bottom zone. as far as I was concerned ....
As for investors momentum being interested in GALT, there was a small bounce off the 4.28 bottom, topping at 6.60 resistance, an GALT has floundered since then. The momentum is kind of weak. compared to a hot stock that makes a soaring bounce back to the higher zones.
I believe in the GALT science and potential....what are investors waiting for....are they prohibited from buying here at the bottom ?
IF there is little momentum, and no fundamental inspiration or ability for institutions to buy , then the basic technical chart pattern, with technical trading ought to allow GALT traders to buy this bottom zone here at 4.70 area and they WILL sell when it returns to test the 6.60 area, and enjoy a decent profit.
and IF GALT continues its rally in a second wave to target the 7.00-7.50 area Traders will sell the next trading gains there.
I would love to see GALT release great fundamental news...and price soars way up to the place where it should be all along...the 10 dollar zone, and I can take some profits there..... but so far, even the 6.50 area looks like a chore to get that far.
thanks in advance for your input....
Recent GALT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 05:50:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:55:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:53:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:52:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:51:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:50:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:48:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:47:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:46:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:44:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:43:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:40:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2024 04:23:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 01:07:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/18/2023 01:41:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 09:15:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 04:42:44 PM
- Form 5 - Annual statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/01/2023 09:50:50 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 12/01/2023 09:38:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/01/2023 01:05:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/15/2023 10:19:22 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/13/2023 02:21:40 PM
- UPDATE – Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update • GlobeNewswire Inc. • 11/13/2023 01:45:52 PM
- Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update • GlobeNewswire Inc. • 11/13/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 12:55:24 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM